NB.1.8.1 triggers COVID crisis in Hong Kong—Global agencies on high alert
NB.1.8.1 variant causes Hong Kong’s worst COVID surge in a year; WHO monitors spread globally as deaths and hospitalizations rise among elderly. Read More
How 3SBio became China’s most watched biotech firm after the Pfizer deal
3SBio is now at the center of global oncology focus after licensing SSGJ-707 to Pfizer. Explore what’s driving its stock surge and strategic ascent. Read More
Akeso’s Gumokimab poised to redefine Psoriasis treatment
Akeso, Inc., a leading biopharmaceutical innovator based in Hong Kong, is making significant strides in the treatment of autoimmune diseases. The company recently announced that ... Read More
China confronts new outbreak: What is HMPV and how does it spread?
China is facing a concerning rise in cases of human metapneumovirus (HMPV), a lesser-known but widely present respiratory virus. The outbreak has drawn the attention ... Read More
G M Polyplast reports Rs 4,292 lakhs revenue in H1 FY25, eyes sustainability growth
G M Polyplast Limited, a prominent player in manufacturing high-quality plastic sheets and granules, has reported revenues of ₹4,292.38 lakhs for the first half of ... Read More
UCO Bank reports 50% surge in Q2 FY 2024-25 profits, boosted by retail and MSME growth
UCO Bank has announced its financial results for the second quarter of FY 2024-25, revealing a substantial increase in its profitability. The state-owned lender posted ... Read More
Samfine Creation stock soars 37% in shocking Nasdaq debut—What’s behind the surge?
Samfine Creation Holdings Group Limited made a sensational debut on the Nasdaq, with its shares skyrocketing by 37% on the first day of trading. The ... Read More
Dubber Corporation launches A$25m equity raising to secure growth ambitions
In a significant financial move, Dubber Corporation Limited has announced a A$25 million equity raising, fully underwritten to secure the company's growth trajectory and fuel ... Read More
Nile Capital Group Holdings acquires minority stake in ABS Global Investments to reshape investment landscape
In a significant development within the investment sector, ABS Global Investments (“ABS”), a distinguished global investment firm, has secured Nile Capital Group Holdings (“Nile”) as ... Read More
Longbridge Group Singapore secures over $100m in funding to accelerate global expansion
Longbridge Group Singapore has announced a significant boost in its funding, having secured over USD $100 million from various investment institutions, including prominent Singaporean consortia. ... Read More